These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 31392668)

  • 1. The Effect of Type 2 Diabetes on Bone Biomechanics.
    Karim L; Rezaee T; Vaidya R
    Curr Osteoporos Rep; 2019 Oct; 17(5):291-300. PubMed ID: 31392668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone microarchitecture, biomechanical properties, and advanced glycation end-products in the proximal femur of adults with type 2 diabetes.
    Karim L; Moulton J; Van Vliet M; Velie K; Robbins A; Malekipour F; Abdeen A; Ayres D; Bouxsein ML
    Bone; 2018 Sep; 114():32-39. PubMed ID: 29857063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction and rescue of skeletal fragility in a high-fat diet mouse model of type 2 diabetes: An in vivo and in vitro approach.
    LLabre JE; Sroga GE; Tice MJL; Vashishth D
    Bone; 2022 Mar; 156():116302. PubMed ID: 34952229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of type 2 diabetes-related non-enzymatic glycation on bone biomechanical properties.
    Karim L; Bouxsein ML
    Bone; 2016 Jan; 82():21-7. PubMed ID: 26211993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of bone fragility in type 2 diabetes: Perspective from an interdisciplinary expert panel.
    Chiodini I; Gaudio A; Palermo A; Napoli N; Vescini F; Falchetti A; Merlotti D; Eller-Vainicher C; Carnevale V; Scillitani A; Pugliese G; Rendina D; Salcuni A; Bertoldo F; Gonnelli S; Nuti R; Toscano V; Triggiani V; Cenci S; Gennari L
    Nutr Metab Cardiovasc Dis; 2021 Jul; 31(8):2210-2233. PubMed ID: 34059385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into bone fragility in diabetes: the crucial role of bone quality on skeletal strength.
    Yamamoto M
    Endocr J; 2015; 62(4):299-308. PubMed ID: 25797364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The paradox of bone mineral density and fracture risk in type 2 diabetes.
    Li GF; Zhao PP; Xiao WJ; Karasik D; Xu YJ; Zheng HF
    Endocrine; 2024 Sep; 85(3):1100-1103. PubMed ID: 38922479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are diabetes microvascular complications risk factors for fragility fracture?
    Almutlaq N; Neyman A; DiMeglio LA
    Curr Opin Endocrinol Diabetes Obes; 2021 Aug; 28(4):354-359. PubMed ID: 33989258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sclerostin Regulation, Microarchitecture, and Advanced Glycation End-Products in the Bone of Elderly Women With Type 2 Diabetes.
    Piccoli A; Cannata F; Strollo R; Pedone C; Leanza G; Russo F; Greto V; Isgrò C; Quattrocchi CC; Massaroni C; Silvestri S; Vadalà G; Bisogno T; Denaro V; Pozzilli P; Tang SY; Silva MJ; Conte C; Papalia R; Maccarrone M; Napoli N
    J Bone Miner Res; 2020 Dec; 35(12):2415-2422. PubMed ID: 32777114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal fragility in diabetes.
    Rubin MR
    Ann N Y Acad Sci; 2017 Aug; 1402(1):18-30. PubMed ID: 28926113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contributors to impaired bone health in type 2 diabetes.
    Sheu A; Greenfield JR; White CP; Center JR
    Trends Endocrinol Metab; 2023 Jan; 34(1):34-48. PubMed ID: 36435679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment and treatment of osteoporosis and fractures in type 2 diabetes.
    Sheu A; Greenfield JR; White CP; Center JR
    Trends Endocrinol Metab; 2022 May; 33(5):333-344. PubMed ID: 35307247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Type 2 Diabetes Mellitus and Antidiabetic Medications on Bone Metabolism.
    Lee HS; Hwang JS
    Curr Diab Rep; 2020 Nov; 20(12):78. PubMed ID: 33247351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology and Management of Type 2 Diabetes Mellitus Bone Fragility.
    Eller-Vainicher C; Cairoli E; Grassi G; Grassi F; Catalano A; Merlotti D; Falchetti A; Gaudio A; Chiodini I; Gennari L
    J Diabetes Res; 2020; 2020():7608964. PubMed ID: 32566682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone mineral density and fracture risk in patients with type 1 and type 2 diabetes mellitus.
    Botushanov NP; Orbetzova MM
    Folia Med (Plovdiv); 2009; 51(4):12-7. PubMed ID: 20232652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skeletal Metabolism, Fracture Risk, and Fracture Outcomes in Type 1 and Type 2 Diabetes.
    Sellmeyer DE; Civitelli R; Hofbauer LC; Khosla S; Lecka-Czernik B; Schwartz AV
    Diabetes; 2016 Jul; 65(7):1757-66. PubMed ID: 27329951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone Fragility in Diabetes and its Management: A Narrative Review.
    Leungsuwan DS; Chandran M
    Drugs; 2024 Sep; 84(9):1111-1134. PubMed ID: 39103693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced glycation endproducts and bone quality: practical implications for people with type 2 diabetes.
    Moseley KF; Du Z; Sacher SE; Ferguson VL; Donnelly E
    Curr Opin Endocrinol Diabetes Obes; 2021 Aug; 28(4):360-370. PubMed ID: 34183538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on the pathogenesis and treatment of skeletal fragility in type 2 diabetes mellitus.
    Khosla S; Samakkarnthai P; Monroe DG; Farr JN
    Nat Rev Endocrinol; 2021 Nov; 17(11):685-697. PubMed ID: 34518671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediabetes and skeletal health.
    Lindsay C; Shieh A
    Curr Opin Endocrinol Diabetes Obes; 2023 Aug; 30(4):200-205. PubMed ID: 37248797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.